178 related articles for article (PubMed ID: 37770200)
21. Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment.
Flores-Borja F; Irshad S; Gordon P; Wong F; Sheriff I; Tutt A; Ng T
J Immunol Res; 2016; 2016():7803091. PubMed ID: 27882334
[TBL] [Abstract][Full Text] [Related]
22. Ex Vivo Tumor-on-a-Chip Platforms to Study Intercellular Interactions within the Tumor Microenvironment.
Kumar V; Varghese S
Adv Healthc Mater; 2019 Feb; 8(4):e1801198. PubMed ID: 30516355
[TBL] [Abstract][Full Text] [Related]
23. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
24. Sortase A: A chemoenzymatic approach for the labeling of cell surfaces.
Kumari P; Bowmik S; Paul SK; Biswas B; Banerjee SK; Murty US; Ravichandiran V; Mohan U
Biotechnol Bioeng; 2021 Dec; 118(12):4577-4589. PubMed ID: 34491580
[TBL] [Abstract][Full Text] [Related]
25. Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway.
Zhuo Y; Li S; Hu W; Zhang Y; Shi Y; Zhang F; Zhang J; Wang J; Liao M; Chen J; Qian H; Li D; Sun C
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35577506
[TBL] [Abstract][Full Text] [Related]
26. Sortase-deficient lactobacilli: effect on immunomodulation and gut retention.
Call EK; Goh YJ; Selle K; Klaenhammer TR; O'Flaherty S
Microbiology (Reading); 2015 Feb; 161(Pt 2):311-321. PubMed ID: 25500495
[TBL] [Abstract][Full Text] [Related]
27. Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy.
de Looff M; de Jong S; Kruyt FAE
Front Immunol; 2019; 10():1530. PubMed ID: 31333662
[TBL] [Abstract][Full Text] [Related]
28. Establishment of Slice Cultures as a Tool to Study the Cancer Immune Microenvironment.
Jiang X; Seo YD; Sullivan KM; Pillarisetty VG
Methods Mol Biol; 2019; 1884():283-295. PubMed ID: 30465211
[TBL] [Abstract][Full Text] [Related]
29. Chemerin Suppresses Breast Cancer Growth by Recruiting Immune Effector Cells Into the Tumor Microenvironment.
Pachynski RK; Wang P; Salazar N; Zheng Y; Nease L; Rosalez J; Leong WI; Virdi G; Rennier K; Shin WJ; Nguyen V; Butcher EC; Zabel BA
Front Immunol; 2019; 10():983. PubMed ID: 31139180
[TBL] [Abstract][Full Text] [Related]
30. Critical immunosuppressive effect of MDSC‑derived exosomes in the tumor microenvironment.
Rashid MH; Borin TF; Ara R; Piranlioglu R; Achyut BR; Korkaya H; Liu Y; Arbab AS
Oncol Rep; 2021 Mar; 45(3):1171-1181. PubMed ID: 33469683
[TBL] [Abstract][Full Text] [Related]
31. Multi-Parameter Quantitative Imaging of Tumor Microenvironments Reveals Perivascular Immune Niches Associated With Anti-Tumor Immunity.
Stoltzfus CR; Sivakumar R; Kunz L; Olin Pope BE; Menietti E; Speziale D; Adelfio R; Bacac M; Colombetti S; Perro M; Gerner MY
Front Immunol; 2021; 12():726492. PubMed ID: 34421928
[TBL] [Abstract][Full Text] [Related]
32. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Balta E; Wabnitz GH; Samstag Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
[TBL] [Abstract][Full Text] [Related]
33. An Engineered Tumor-on-a-Chip Device with Breast Cancer-Immune Cell Interactions for Assessing T-cell Recruitment.
Aung A; Kumar V; Theprungsirikul J; Davey SK; Varghese S
Cancer Res; 2020 Jan; 80(2):263-275. PubMed ID: 31744818
[TBL] [Abstract][Full Text] [Related]
34. Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity.
Gao A; Liu X; Lin W; Wang J; Wang S; Si F; Huang L; Zhao Y; Sun Y; Peng G
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33653799
[TBL] [Abstract][Full Text] [Related]
35. Lipid modification of proteins through sortase-catalyzed transpeptidation.
Antos JM; Miller GM; Grotenbreg GM; Ploegh HL
J Am Chem Soc; 2008 Dec; 130(48):16338-43. PubMed ID: 18989959
[TBL] [Abstract][Full Text] [Related]
36. Elimination of melanoma by sortase A-generated TCR-like antibody-drug conjugates (TL-ADCs) targeting intracellular melanoma antigen MART-1.
Lai J; Wang Y; Wu SS; Ding D; Sun ZY; Zhang Y; Zhou J; Zhou Z; Xu YC; Pan LQ; Chen SQ
Biomaterials; 2018 Sep; 178():158-169. PubMed ID: 29933102
[TBL] [Abstract][Full Text] [Related]
37. Tumor-immune dynamics regulated in the microenvironment inform the transient nature of immune-induced tumor dormancy.
Wilkie KP; Hahnfeldt P
Cancer Res; 2013 Jun; 73(12):3534-44. PubMed ID: 23536560
[TBL] [Abstract][Full Text] [Related]
38. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol for targeting the tumor microenvironment and its interactions with cancer cells.
Mu Q; Najafi M
Int Immunopharmacol; 2021 Sep; 98():107895. PubMed ID: 34171623
[TBL] [Abstract][Full Text] [Related]
40. Immune Landscape in Tumor Microenvironment: Implications for Biomarker Development and Immunotherapy.
Pérez-Romero K; Rodríguez RM; Amedei A; Barceló-Coblijn G; Lopez DH
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
